Home › Research › Brain scans and imaging
Association of in vivo retention of [18f] flortaucipir pet with tau neuropathology in corresponding brain regions
Freiburghaus T, Pawlik D, Oliveira Hauer K, Ossenkoppele R, Strandberg O, Leuzy A, Rittmo J, Tremblay C et al.. Acta neuropathologica, 2024-09-19
Topic: Brain proteins, microglia and lab models
Plain-language summary
[ 18 F]Flortaucipir is an FDA-approved tau-PET tracer that is increasingly utilized in clinical settings for the diagnosis of Alzheimer's disease. Still, a large-scale comparison of the in vivo PET uptake to quantitative post-mortem tau pathology and to other co-pathologies is lacking. Here, we examined the correlation between in vivo [ 18 F]flortaucipir PET uptake and quantitative post-mortem tau pathology in corresponding brain regions from the AVID A16 end-of-life study (n = 63). All participants underwent [ 18 F]flortaucipir PET scans prior to death, followed by a detailed post-mortem neuropathological examination using AT8 (tau) immunohistochemistry. Correlations between [ 18 F]flortaucipir standardized uptake value ratios (SUVRs) and AT8 immunohistochemistry were assessed across 18 regions-of-interest (ROIs). To assess [ 18 F]flortaucipir specificity and level of detection for tau pathology, correlations between [ 18 F]flortaucipir SUVR and neuritic plaque score and TDP-43 stage were also computed and retention was further assessed in individuals with possible primary age-related tauopathy (PART), defined as Thal phase ≤ 2 and Braak stage I-IV. We found modest-to-strong correlations between in vivo [ 18 F]flortaucipir SUVR and post-mortem tau pathology density in corresponding brain regions in all neocortical regions analyzed (rho-range = 0.61-0.79, p < 0.0001 for all). The detection threshold of [ 18 F]flortaucipir PET was determined to be 0.85% of surface area affected by tau pathology in a temporal meta-ROI, and 0.15% in a larger cortical meta-ROI. No significant associations were found between [ 18 F]flortaucipir SUVRs and post-mortem tau pathology in individuals with possible PART. Further, there was no correlation observed between [ 18 F]flortaucipir and level of amyloid-β neuritic plaque load (rho-range = - 0.16-0.12; p = 0.48-0.61) or TDP-43 stage (rho-range = - 0.10 to - 0.30; p = 0.18-0.65). In conclusion, our in vivo vs post-mortem study shows that the in vivo [ 18 F]flortaucipir PET signal primarily reflects tau pathology, also at relatively low densities of tau proteinopathy, and does not bind substantially to tau neurites in neuritic plaques or in individuals with PART.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Freiburghaus, T., Pawlik, D., Oliveira Hauer, K., Ossenkoppele, R., Strandberg, O., Leuzy, A., et al. (2024). Association of in vivo retention of [18f] flortaucipir pet with tau neuropathology in corresponding brain regions. Acta neuropathologica. https://doi.org/10.1007/s00401-024-02801-2
Vancouver
Freiburghaus T, Pawlik D, Oliveira Hauer K, Ossenkoppele R, Strandberg O, Leuzy A, et al. Association of in vivo retention of [18f] flortaucipir pet with tau neuropathology in corresponding brain regions. Acta neuropathologica. 2024. doi:10.1007/s00401-024-02801-2. PMID: 39297933.
BibTeX
@article{freiburghaus2024-39297933,
author = {Freiburghaus, T. and Pawlik, D. and Oliveira Hauer, K. and Ossenkoppele, R. and Strandberg, O. and Leuzy, A. and Rittmo, J. and Tremblay, C. and others},
title = {{Association of in vivo retention of [18f] flortaucipir pet with tau neuropathology in corresponding brain regions}},
journal = {Acta neuropathologica},
year = {2024},
doi = {10.1007/s00401-024-02801-2},
pmid = {39297933},
url = {https://doi.org/10.1007/s00401-024-02801-2}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- We found modest-to-strong correlations between in vivo [ 18 F]flortaucipir SUVR and post-mortem tau pathology density in corresponding brain regions in all neocortical regions analyzed (rho-range = 0.61-0.79, p < 0.0001 for all).
- No significant associations were found between [ 18 F]flortaucipir SUVRs and post-mortem tau pathology in individuals with possible PART.
- In conclusion, our in vivo vs post-mortem study shows that the in vivo [ 18 F]flortaucipir PET signal primarily reflects tau pathology, also at relatively low densities of tau proteinopathy, and does not bind substantially to tau neurites in neuritic plaques or in individuals with PART.
New to this subject? Start with our plain-English guide: Brain scans & tests →
Study details
- Participants63
- Effect size0.85%; 0.15%
- Evidence strengthLow
How this study scored 59/100
Published in a leading specialty journal. Scored zero for study design and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 34 of the 58 points we could judge it on, which is 59 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Acta neuropathologica) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2024 — within 3 year(s) of the newest study here |
| Sample size | 1 / 4 | 63 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39297933) |
| Free to read | 2 / 2 | Free to read |
| Points | 34 / 58 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 34 of the 58 points we could judge it on is 59 out of 100. |
| Total | 59 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Brain scans and imaging from nearby years
Also tagged “flortaucipir-pet”
3 studies in the library carry the topic tag “flortaucipir-pet”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 3 tagged studies.